carbapenems has been researched along with propranolol in 1 studies
| Studies (carbapenems) | Trials (carbapenems) | Recent Studies (post-2010) (carbapenems) | Studies (propranolol) | Trials (propranolol) | Recent Studies (post-2010) (propranolol) |
|---|---|---|---|---|---|
| 7,355 | 147 | 5,277 | 33,310 | 3,406 | 3,218 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdellatif, GR; Aboshanab, KM; Mabrouk, SS; Zaid, ASA | 1 |
1 other study(ies) available for carbapenems and propranolol
| Article | Year |
|---|---|
Propranolol restores susceptibility of XDR Gram-negative pathogens to meropenem and Meropenem combination has been evaluated with either tigecycline or amikacin.
Topics: Amikacin; Carbapenems; Escherichia coli; Humans; Meropenem; Propranolol; Tigecycline | 2023 |